Platform Issue Survey

Introduction: Your Expression Platform

For our July–August issue this year, the editors of BioProcess International and BioProcess Insider come together to report on the past year in upstream production, downstream processing, analytical methods, and product development for biopharmaceutical products. But this is your “Expression Platform,” and we want to present your voice along with ours and those of our contributors. This survey is your place to weigh in on the state of the industry today.

After entering the following basic information, you’ll be offered the choice of answering a few more questions that are specific to your area of interest. At the end, you’ll have the option of providing contact information for entry into drawings to win an Amazon voucher or one of four free passes to the BPI Conference of your choice. You’ll also have the chance to make yourself available for editorial follow-up. We look forward to hearing from you and presenting the survey results this summer.

Question Title

* 1. Which of the following best describes your current role? (Check all that apply.)

Management

Business development

CMC/MSAT scientist

QA/QC, compliance

Analytical/formulation

Process engineering

Drug discovery

Marketing/sales

Regulatory affairs

Information technology

Human resources, training

Academic/researcher

Regulator/reviewer

Other (please specify)

Question Title

* 2. Your experience working in the biopharmaceutical industry:

<5 years

5-10 years

10-15 years

15-20 years

>20 years

Question Title

* 3. When was the last time you changed employers?

<1 year ago

1–3 years ago

3–6 years ago

6–10 years ago

>10 years ago

Question Title

* 4. What product modalities does your current company work with? (Check all that apply.)

Nonantibody proteins (e.g., enzymes, cytokines)

Antibodies/derivatives (e.g., monoclonal, bispecific, fragments)

Fusion proteins, conjugates

Facility Engineering

Gene/cell therapy

Tissue therapy, regenerative medicine

Biosimilars

Vaccines

Peptides

Other (e.g., oligonucleotides, mRNA)

None (e.g., technology supplier)

Question Title

* 5. How much are supply-chain concerns still influencing your company’s overall operations?

Not at all

Somewhat

Quite a bit

A great deal

Question Title

* 6. What do you think about using artificial intelligence (AI) to assist in biopharmaceutical development and manufacturing?

AI could be detrimental to the security of biopharmaceutical operations and/or intellectual property

AI adoption may be useful in the future, but it does not have significant utility at this time

AI provides important tools to developers and is making a difference in the industry today

AI adoption already is critical to our operations, and companies that do not implement it will fall behind

Other (please specify)

Question Title

* 7. What is your current primary area of expertise?

Upstream production (e.g., cell-line development, cell culture)

Downstream processing (e.g., separation, purification, drug substance)

Analytical/product development (e.g., QA/QC, characterization, drug-product formulation)

Business/regulatory (e.g., management, staffing, licensing, business development)